| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/15/2001 | WO2001010893A2 Il-16 antagonists |
| 02/15/2001 | WO2001010887A2 Multi-functional antimicrobial peptides |
| 02/15/2001 | WO2001010469A2 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 02/15/2001 | WO2001010462A1 Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-cd20 antibodies |
| 02/15/2001 | WO2001010461A1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 02/15/2001 | WO2001010460A1 Treatment of intermediate- and high-grade non-hodgkins lymphoma with anti-cd20 antibody |
| 02/15/2001 | WO2001010459A2 Fish vaccine |
| 02/15/2001 | WO2001010448A1 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| 02/15/2001 | WO2001010413A2 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 02/15/2001 | WO2001010221A1 Vaccines for the treatment of autoimmune disease |
| 02/15/2001 | WO2000071724A3 Novel compounds from moraxella catarrhalis |
| 02/15/2001 | WO2000068384A3 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS |
| 02/15/2001 | WO2000064946A3 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 02/15/2001 | WO2000063403A3 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/15/2001 | WO2000061184A3 Dry formulation for transcutaneous immunization |
| 02/15/2001 | WO2000058456A3 Compositions and methods for modifying toxic effects of proteinacious compounds |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000052165A3 Compositions and methods for breast cancer therapy and diagnosis |
| 02/15/2001 | WO2000039154A8 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 02/15/2001 | WO2000002573A8 Natural composition and method for the treatment of sexual dysfunction |
| 02/15/2001 | CA2383230A1 Tumor-associated antigen (r11) |
| 02/15/2001 | CA2381699A1 Novel methods of diagnosis of angiogenesis compostions and methods of screening for angiogenesis modulators |
| 02/15/2001 | CA2381396A1 Polynucleotides and polypeptides encoded thereby |
| 02/15/2001 | CA2381293A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2380398A1 Annexins and autoantibodies used as markers for cancer |
| 02/15/2001 | CA2379087A1 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 02/15/2001 | CA2378646A1 Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-cd20 antibodies |
| 02/15/2001 | CA2378620A1 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| 02/15/2001 | CA2378437A1 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 02/15/2001 | CA2378285A1 Vaccines for the treatment of autoimmune disease |
| 02/15/2001 | CA2377422A1 Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof |
| 02/14/2001 | EP1075841A1 Pneumococcal vaccines |
| 02/14/2001 | EP1075537A1 Bacteriophage assay |
| 02/14/2001 | EP1075535A1 A method for diagnosing and treating chronic pelvic pain syndrome |
| 02/14/2001 | EP1075524A2 Attenuated influenza viruses |
| 02/14/2001 | EP1075523A2 Structural proteins of fish pancreatic disease virus and uses thereof |
| 02/14/2001 | EP1075521A2 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/14/2001 | EP1075520A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 02/14/2001 | EP1075494A2 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 02/14/2001 | EP1075493A2 Dna encoding snorf25 receptor |
| 02/14/2001 | EP1075490A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 02/14/2001 | EP1075277A2 Methods for detecting and inhibiting angiogenesis |
| 02/14/2001 | EP1075276A2 Adjuvant composition and methods for its use |
| 02/14/2001 | EP1075275A1 Use of interleukin-18 as vaccine adjuvant |
| 02/14/2001 | EP1075274A2 Immunomodulators for vaccines |
| 02/14/2001 | EP1075272A1 Methods for treating diabetes by inhibiting gdf-8 |
| 02/14/2001 | EP1075271A2 Method of treating interstitial cystitis with recombinant heparin-binding epidermal growth factor-like growth factor (hb-egf) |
| 02/14/2001 | EP1075255A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof |
| 02/14/2001 | EP1075184A1 Compositions and methods for active vaccination |
| 02/14/2001 | EP0708767B1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 02/13/2001 | US6187908 Tubby 2 polypeptides |
| 02/13/2001 | US6187803 Treating allergic disease, autoimmune disease, immunodeficiency syndrome, inflammatory disease or eosinophilia by orally administering a histamine-added immunoglobulin and carrier; tablets, capsules |
| 02/13/2001 | US6187759 Canine parvovirus DNA vaccination |
| 02/13/2001 | US6187748 Treatment and prevention of hiv |
| 02/13/2001 | US6187593 Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein |
| 02/13/2001 | US6187562 Polynucleotides encoding human sphingosine Lyase |
| 02/13/2001 | US6187561 Nucleotide sequence coding enzymatic polypeptide associated with charging molecule during translation; for detection of bactericides; for antibiotic prophylaxis before dental treatment; for prevention of infections; wound healing agents |
| 02/13/2001 | US6187335 Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom |
| 02/13/2001 | US6187320 Which contain foreign dna elements in addition to the genome sequences necessary for the replication. |
| 02/13/2001 | US6187319 Administering to the animal an isolated vp6 polypeptide of a second rotavirus sufficient to produce an effective immune response against the first rotavirus, the second rotavirus capable of infecting a different species than the first |
| 02/13/2001 | US6187318 Oils dampen the friction of the soft tissue and diminish the noise associated with snoring. |
| 02/13/2001 | US6187315 Compositions and methods of treating cancer with tannin complexes |
| 02/13/2001 | US6187312 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of infectious diseases |
| 02/13/2001 | US6187309 Method for treatment of symptoms of central nervous system disorders |
| 02/13/2001 | US6187308 Ameliorating an immune response disorder. |
| 02/13/2001 | US6187307 Cancer immunotherapy with semi-allogeneic cells |
| 02/13/2001 | US6187306 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 02/13/2001 | US6187287 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells |
| 02/13/2001 | CA2160486C Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 02/13/2001 | CA2127117C Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |
| 02/13/2001 | CA2079230C Bcrf1 antagonists for treating epstein-barr virus infections |
| 02/08/2001 | WO2001009361A1 Recombinant hsv-1 and live viral vaccines |
| 02/08/2001 | WO2001009350A2 Genetically engineered bleb vaccine |
| 02/08/2001 | WO2001009340A1 Proteins derived from white spot syndrome virus and uses thereof |
| 02/08/2001 | WO2001009339A2 Moraxella catarrhalis antigen basb117 |
| 02/08/2001 | WO2001009338A1 Basb116 dna and proteins from moraxella catarrhalis |
| 02/08/2001 | WO2001009337A2 Moraxella catarrhalis antigens basb122 and basb124 |
| 02/08/2001 | WO2001009336A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009335A2 Moraxella catarrhalis antigen basb120 |
| 02/08/2001 | WO2001009334A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009333A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 02/08/2001 | WO2001009332A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 02/08/2001 | WO2001009331A2 Moraxella catarrhalis antigen basb125 |
| 02/08/2001 | WO2001009330A2 Moraxella catarrhalis antigen basb121 |
| 02/08/2001 | WO2001009329A1 Basb126 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009309A2 RESCUE OF MUMPS VIRUS FROM cDNA |
| 02/08/2001 | WO2001009303A2 Flt-3 LIGAND-ENCODING POLYNUCLEOTIDE AS A POLYNUCLEOTIDE-BASED VACCINE ENHANCER |
| 02/08/2001 | WO2001009298A2 Strategy for carbohydrate-based cancer vaccines |
| 02/08/2001 | WO2001009293A2 Mammalian adhesion protease peptides |
| 02/08/2001 | WO2001009291A1 Attenuated influenza virus useful as vaccine |
| 02/08/2001 | WO2001009290A2 Avian infectious bronchitis virus serotype |
| 02/08/2001 | WO2001009289A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 02/08/2001 | WO2001009287A2 Pressure treatment of cells |
| 02/08/2001 | WO2001009193A1 Chimeric polypeptides, method for production and uses thereof |
| 02/08/2001 | WO2001009192A1 Human monoclonal antibodies to prostate specific membrane antigen |
| 02/08/2001 | WO2001009189A2 Compositions and methods for the treatment of tumors |
| 02/08/2001 | WO2001009187A2 Human monoclonal antibodies to her2/neu |
| 02/08/2001 | WO2001009179A1 Moraxella cattarrhalis basb114 antigens and uses thereof |